These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 22288441)
1. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Grainge MJ; West J; Solaymani-Dodaran M; Card TR; Logan RF Aliment Pharmacol Ther; 2012 Mar; 35(6):730-9. PubMed ID: 22288441 [TBL] [Abstract][Full Text] [Related]
2. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Viljamaa M; Kaukinen K; Pukkala E; Hervonen K; Reunala T; Collin P Dig Liver Dis; 2006 Jun; 38(6):374-80. PubMed ID: 16627018 [TBL] [Abstract][Full Text] [Related]
3. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Card TR; West J; Holmes GK Aliment Pharmacol Ther; 2004 Oct; 20(7):769-75. PubMed ID: 15379837 [TBL] [Abstract][Full Text] [Related]
4. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Collin P; Pukkala E; Reunala T Gut; 1996 Apr; 38(4):528-30. PubMed ID: 8707082 [TBL] [Abstract][Full Text] [Related]
5. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Lewis NR; Logan RF; Hubbard RB; West J Aliment Pharmacol Ther; 2008 Jun; 27(11):1140-7. PubMed ID: 18315580 [TBL] [Abstract][Full Text] [Related]
6. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Smedby KE; Akerman M; Hildebrand H; Glimelius B; Ekbom A; Askling J Gut; 2005 Jan; 54(1):54-9. PubMed ID: 15591504 [TBL] [Abstract][Full Text] [Related]
7. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study. Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC Haematologica; 2006 Nov; 91(11):1481-8. PubMed ID: 17043014 [TBL] [Abstract][Full Text] [Related]
8. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277 [TBL] [Abstract][Full Text] [Related]
9. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718 [TBL] [Abstract][Full Text] [Related]
10. Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Lohi S; Mäki M; Montonen J; Knekt P; Pukkala E; Reunanen A; Kaukinen K Gut; 2009 May; 58(5):643-7. PubMed ID: 18852259 [TBL] [Abstract][Full Text] [Related]
11. Mortality in people with coeliac disease: Long-term follow-up from a Scottish cohort. Quarpong W; Card TR; West J; Solaymani-Dodaran M; Logan RF; Grainge MJ United European Gastroenterol J; 2019 Apr; 7(3):377-387. PubMed ID: 31019706 [TBL] [Abstract][Full Text] [Related]
12. Incidence of cancer among patients with atopic dermatitis. Hagströmer L; Ye W; Nyrén O; Emtestam L Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309 [TBL] [Abstract][Full Text] [Related]
13. Moderately increased risk of urinary stone disease in patients with biopsy-verified coeliac disease. Ludvigsson JF; Zingone F; Fored M; Ciacci C; Cirillo M Aliment Pharmacol Ther; 2012 Feb; 35(4):477-84. PubMed ID: 22221254 [TBL] [Abstract][Full Text] [Related]
14. Cancer incidence in blood transfusion recipients. Hjalgrim H; Edgren G; Rostgaard K; Reilly M; Tran TN; Titlestad KE; Shanwell A; Jersild C; Adami J; Wikman A; Gridley G; Wideroff L; Nyrén O; Melbye M J Natl Cancer Inst; 2007 Dec; 99(24):1864-74. PubMed ID: 18073377 [TBL] [Abstract][Full Text] [Related]
15. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study. Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465 [TBL] [Abstract][Full Text] [Related]
16. Occupation and cancer - follow-up of 15 million people in five Nordic countries. Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375 [TBL] [Abstract][Full Text] [Related]
17. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
18. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293 [TBL] [Abstract][Full Text] [Related]
19. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271 [TBL] [Abstract][Full Text] [Related]
20. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]